Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Armodafinil in Binge Eating Disorder
NCT01010789Phase 3Completed
- Sponsor
- Lindner Center of HOPE
- Start
- Nov 2009
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of armodafinil in binge eating disorder (BED), sponsored by Lindner Center of HOPE. Started Nov 2009; status: completed.
02
Drugs
armodafinil
03
Conditions
binge eating disorder (BED)
Beyond the preview
Go deeper on NCT01010789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01010789.